Skip to main content

ERRATUM article

Front. Genet., 02 June 2023
Sec. Cancer Genetics and Oncogenomics
Volume 14 - 2023 | https://doi.org/10.3389/fgene.2023.1228830
This article is part of the Research Topic Current Trends and Future Perspectives about Liquid Biopsy View all 6 articles

Erratum: Application of circulating tumour DNA in terms of prognosis prediction in chinese follicular lymphoma patients

This article is an erratum on:

  1. Application of circulating tumour DNA in terms of prognosis prediction in Chinese follicular lymphoma patients

    1. Read original article
Frontiers Production Office Frontiers Production Office*
  • Frontiers Media SA, Lausanne, Switzerland

An Erratum on
Application of circulating tumour DNA in terms of prognosis prediction in chinese follicular lymphoma patients

by Zhao M, Li Q, Yang J, Zhang M, Liu X, Zhang H, Huang Y, Li J, Bao J, Wang J, Du J, Guan T and Su L (2023). Front. Genet. 14:1066808. doi: 10.3389/fgene.2023.1066808

Due to a production error, there was a mistake in Figure 1 as published. The figure was inadvertently duplicated from Supplementary Figure S1. The correct Figure 1 appears below.

FIGURE 1
www.frontiersin.org

FIGURE 1. Mutation landscape of the ctDNA samples in newly diagnosed FL patients. The X-axis is the sample of individual patients. The upper histogram represents the number of mutated genes per sample. The Y-axis on the left shows the mutated genes, and the percentages on the right chart represent the mutation frequency of mutated genes.

The publisher apologizes for these mistakes. The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: follicular lymphoma, circulating tumour DNA, targeted next-generation sequencing, mutation, prognosis

Citation: Frontiers Production Office (2023) Erratum: Application of circulating tumour DNA in terms of prognosis prediction in chinese follicular lymphoma patients. Front. Genet. 14:1228830. doi: 10.3389/fgene.2023.1228830

Received: 25 May 2023; Accepted: 25 May 2023;
Published: 02 June 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Frontiers Production Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Production Office, production.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.